Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: Temporal and spatial analysis using in situ hybridization

Journal of Neurotrauma

Volumn 15, Issue 7, 1998, Pages 485-494

  Tachibana, Toshiya ^a   Miki, Kenji ^a   Fukuoka, Tetsuo ^a   Arakawa, Akira ^a   Taniguchi, Mutsumi ^a   Maruo, Soji ^a   Noguchi, Koichi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Dorsal horn; Dynorphin; In situ hybridization; mRNA; Rats; Spinal cord injury

Indexed keywords

DYNORPHIN;

ANIMAL TISSUE; ARTICLE; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY;

EID: 0031839161     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1998.15.485     Document Type: Article

References (33)

1. ALLEN, A.R. (1911). Surgery of experimental lesion of spinal cord equivalent to crash injury of fracture dislocation of spinal column. J.A.M.A. 57, 878-880.
2. BAKSHI, R., NEWMAN, A.H., and FADEN, A.I. (1990). Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism. J. Neurosci. 10, 3793-800.
3. BAKSHI, R., NI, R.-X., and FADEN, A.I. (1992). N-Methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury, behavioral and histological studies. Brain Res. 580, 255-264.
4. BASBAUM, A.I., CRUZ, L., and WEBER, E. (1986). Immunoreactive dynorphin B in sacral primary afferent fibres of the cat. J. Neurosci. 6, 127-133.
5. BOTTICELLI, I.J., COX, B.M., and GOLDSTEIN, A. (1981). Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proc. Anat. Acad. Sci. U.S.A. 78, 7783-7786.
6. CIVELLI, O., DOUGLASS, J., GOLDSTEIN, A., and HERBERT, E. (1985). Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. U.S.A. 82, 4291-4295.
7. DRAISCI, G., and IADAROLA, M.J. (1989). Temporal analysis of increase in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6, 31-37.
8. FADEN, A.I. (1990). Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann. Neurol. 27, 67-74.
9. FADEN, A.I. (1992). Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J. Neurosci. 12, 425-429.
10. FADEN, A.I. (1993). Exprimental neurobiology of central nervous system injury, in: Critical Reviews in Neurobiology 7. C.B. Nemeroff (ed), CRC Press: Boca Raton, FL, pps. 175-186.
11. FADEN, A.I., JACOBS, T.P., and HOLADAY, J.W. (1981). Opiate antagonist improves neurologic recovery after spinal injury. Science 211, 493-494.
12. FADEN, A.I., MOLINEAUX, C.J., ROSENBERGER, J.G., JACOBS, T.P., and COX, B.M. (1985). Increased dynorphin immunoreactivity in spinal cord after traumatic injury. Regul. Pept. 11, 35-41.
13. FADEN, A.I., TAKEMORI, A.E., and PROTOGHEE, P.S. (1987). k-selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats. CNS Trauma 4, 227-237.
14. HALL, E.D., and BRAUGHLER, J.M. (1993). Free radicals in CNS injury, in: Molecular and Cellular Approaches to the Treatment of Neurological Disease. S.G. Waxmon (ed), Raven Press: New York, pps. 81-105.
15. HERMAN, B.H., and GOLDSTEIN, A. (1985). Antinociception and paralysis induced by intrathecal dynorphin A. J. Pharmacol. Exp. Ther. 232, 27-35.
16. HONMOU, O., and YOUNG, W. (1995). Traumatic injury of spinal axons, in: The Axon. Structure, Function and Pathophysiology. S.G. Waxman, J.D. Kocsis, and P.K. Stys (eds), Oxford University Press: New York, pps. 480-503.
17. LONG, J.B., RIGAMONTI, D.D., OLENSYANSKY, M.A., WINGFIELD, C.P., and MARTINEZ, A.A. (1994). Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J. Pharmacol. Exp. Ther. 269, 358-366.
18. MILLER, K.E., and SEYBOLD, V.S. (1987). Comparison of met-enkephalin, dynorphin A-, and neurotensin-immunoreactive neurons in the cat and rat spinal cords. II. Segmental differences in the marginal zone. J. Comp. Neurol. 279, 619-628.
19. MULLEN, R.J., BUCK, C.R., and SMITH, A.M. (1992). NeuN. a neuronal specific nuclear protein in vertebrates. Development 116, 201-211.
20. NARANJO, J.R., MELLSTROM, B., ACHAVAL, M., and SASSONE-CORSI, P. (1991). Molecular pathways of pain: fos/jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 6, 607-617.
21. NOBLE, L.J., and WRATHALL, J.R. (1985). Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp. Neurol. 88, 135-149.
22. NOBLE, L.J., and WRATHALL, J.R. (1989). Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp. Neurol. 103, 34-40.
23. NOGUCHI, K., KOWALSKI, R., TRAUB, R., SOLODKIN, A., IADOROLA, M.J., and RUDA, M.A. (1991). Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol. Brain Res. 10, 227-233.
24. PRZEWLOCKI, R., HAARMANN, I., NIKOLARAKIS, K., HERZ, A., and HÖLLT, V. (1988). Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. Brain Res. 464, 37-41.
25. PRZEWLOCKI, R., SHEARMAN, G.T., and HERZ, A. (1983). Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats. Neuropeptides 3, 233-240.
26. RIVLIN, A.S., and TATOR, C.H. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47, 577-581.
27. RUDA, M.A., IADAROLA, J., CHOEN, L.V.A., and YOUNG, W.S., III (1988). In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in rat model of peripheral inflammation and hyperalgesia. Proc. Natl. Acad. Sci. U.S.A. 85, 622-626.
28. SHARMA, H.S., NYBERG, F., and OLSSON, Y. (1992). Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique. Neurosci. Res. 14, 195-203.
29. STEWART, P., and ISSAC, ML. (1989). Localization of dynorphin-induced toxicity in rat spinal cord. Life Sci. 44, 1505-1514.
30. SUHONEN, J.O., PETERSON, D.A., RAY, J., and GAGE, F.H. (1996). Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature 383, 624-627.
31. TACHIBANA, T., ARAKAWA, A., MARUO, S., MIKI, K., TOKUNAGA, A., and NOGUCHI, K. (1996). Dynorphin expression in dorsal horn neurons following traumatic spinal cord injury. Soc. Neurosci. Abst. 22, 231.
32. TRACEY, D.J. (1995). Ascending and descending pathways in the spinal cord, in: The Rat Nervous System. 2nd ed. G. Paxinos (ed), Academic Press, Inc.: San Diego, pps. 67-80.
33. YAKOVLEV, A.G., and FADEN, A.I. (1994). Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol. Chem. Neuropathol. 23, 179-190.